West Lafayette, IN, United States of America

Antonella Pepe

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Purdue Research Foundation. Active years: 2021-2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antonella Pepe: Innovator in Pharmaceutical Research

Introduction

Antonella Pepe is a prominent inventor based in West Lafayette, Indiana, known for her significant contributions to pharmaceutical research. She has been instrumental in developing innovative compounds that target critical biological processes. With a total of two patents to her name, her work focuses on addressing diseases mediated by the malfunction of specific proteins.

Latest Patents

Antonella's latest patents include the development of 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles. These compounds serve as inhibitors of ubiquitin specific protease 7 (USP7), which is crucial for treating various diseases such as inflammation, cancer, and immunological disorders. The inventions also encompass pharmaceutical compositions and methods for effectively treating these diseases in mammals.

Career Highlights

Antonella is affiliated with the Purdue Research Foundation, where she conducts her research and development activities. Her work has garnered attention for its potential impact on therapeutic strategies in the medical field.

Collaborations

Antonella collaborates with Andrew Mesecar, a fellow researcher, to further advance their understanding and application of USP7 inhibitors in medical treatments.

Conclusion

Antonella Pepe's innovative work in pharmaceutical research highlights her commitment to developing effective treatments for serious health conditions. Her contributions continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…